Robert Bruce's Strategic Move: LyondellBasell Industries NV Takes Center Stage in Q2 2025 13F Filing

viernes, 15 de agosto de 2025, 10:09 am ET1 min de lectura
LYB--

Robert Bruce, founder of Bruce & Co, has made significant moves in his 13F filing for Q2 2025. Notably, he added LyondellBasell Industries NV with 40,000 shares, accounting for 0.75% of the portfolio. He also increased stakes in Vicor Corp and The Chemours Co, while completely exiting Organon & Co and IGM Biosciences Inc. Additionally, he reduced positions in CMS Energy Corp and Merck & Co Inc.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios